From a survey of 10 analysts, consensus for FY 19 is:

 

Range (£m) 

Average (mean, £m)

Sales 

943.2 - 969.7

953.0

EBITDA (pre-IFRS16) 

118.5 – 125.2

120.7

 

  

From a survey of 9 analysts, consensus for H1 19 is:

 

Range (£m) 

Average (mean, £m)

Sales 

479.0-495.4

485.5

EBITDA (pre-IFRS16) 

59.0-66.9

62.9

 

931.1m
revenue in 2018
7,700+
dedicated clinicians and clinical support staff
96%
patients ‘Likely’ or ‘Extremely Likely’ to recommend Spire Healthcare